Powered by
-
INCY Stock Chart
Historical INCY Prices
INCYTE RG Stock Analysis
Rating: Strong Sell
Total Grade: F
Analysis Breakdown
| INCY Stock Grade: | F |
| Fundamental Grade: | D |
| Quantitative Grade: | F |
| INCY Earnings | |
| Earnings Growth: | F |
| Earnings Momentum: | B |
| Earnings Surprises: | F |
| Analyst Earnings Revisions: | F |
| INCY Financial Information | |
| Sales Growth: | A |
| Operating Margin Growth: | F |
| Cash Flow: | F |
| Return on Equity: | F |
INCYTE RG Stock: Weekly View
| This Week: | F |
|---|---|
| Last Week: | F |
| Two Weeks Ago: | F |
INCY Stock predictions, Articles, and INCYTE RG News
- From InvestorPlace
- From the Web
-
Incyte Corporation Stock Plunges on Melanoma Drug Trial Failure - April 6, 2018
Incyte (INCY) was falling hard on Friday following news of a failed Phase 3 drug trial for its melanoma drug epacadostat. Continue…
-
10 Deceptively Bad Stocks to Sell Before You’re Pranked - March 30, 2018
If you’re itching to buy, avoid these stocks at all costs. Here's what makes them stocks to sell for all wise investors. Continue…
-
10 Secret Stocks Top Investors Are Betting On - February 1, 2018
Here are the 10 stock picks top investors are betting on right now. We take a look at how investors are trading these stocks -- and whether the Street agrees. Continue…
-
5 Big Biotech Stocks To Buy In 2018 - January 17, 2018
Biotech stocks had a great run in 2017. The new year could have more big gains ahead. Here are 5 top biotech stocks to buy today. Continue…
-
5 Stocks the Top Fund Managers Love - November 20, 2017
These top hedge fund stocks all have a 'very positive' confidence sentiment for the quarter and a 'Strong Buy' outlook from the Street. Continue…
-
Vapid Earnings Visibility Restrict Incyte (INCY) Rating - November 6, 2017
Incyte Corp (NASDAQ:INCY) is a $22.2 billion in market value member of the Biotechnology GICS industry group where Portfolio Grader's current ranking for INCY puts it 171 among the 349 companies in this industry group, placing it in the top half. INCY is ranked in the third quartile of the sector with a ranking of 402 among the 785 companies in the sector and number 2,601 in the 5000 company Portfolio Grader company universe. Continue…
-
5 Toxic Stocks to Abandon or Sell Short for Gains - October 12, 2017
Toxic stocks are susceptible to external shocks and are loaded with high amounts of debts. Also, the price of toxic stocks is irrationally high. Continue…
-
5 Toxic Stocks to Discard or Sell Short for Profit - September 22, 2017
Toxic stocks are exposed to outside shocks and are burdened with high levels of debts. Also, the price of toxic stocks is artificially inflated. Continue…
-
5 of the Toughest Stocks to Withstand a Downturn - September 18, 2017
These downturn-proof stocks to buy are much tougher than most on the market. Here's why each are among the toughest stocks to own. Continue…
-
5 Biotech Stocks That Are Breaking Higher - August 30, 2017
Biotech stocks are surging amid M&A speculation after Gilead agreed to buy Kite Pharma. And these biotechs are moving higher in response. Continue…
